≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

Endpoint Browser PheWeb

CD2_TNK_LYMPHOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C84
  • Cause of death: ICD-10 — C84

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF12
Parent code in ICD-10
C81-C96
Name in latin
Lymphomata T-cellularia peripherica et cutanea

Similar endpoints

↥

List of similar endpoints to Mature T/NK-cell lymphomas, hilmo, excluding all cancers based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 458 166 292
Unadjusted period prevalence (%) 0.10 0.06 0.13
Median age at first event (years) 65.19 64.58 65.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
415
Matched controls
4148
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
218.7
190
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
156.3
188.3
189
22
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
120.9
110
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
19.6
102.2
165
135
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
99.0
91
*
L03AA02
ATC
filgrastim; parenteral
1093.8
92.5
87
*
JN4BD
NOMESCO Finland
Extensive body CT
21.4
89.9
138
94
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
74.2
69
*
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
73.1
68
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
70.9
66
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
68.7
64
*
XW000
NOMESCO Finland
Bone marrow biopsy
23.6
68.4
100
55
A03FA01
ATC
metoclopramide; systemic, rectal
9.7
63.0
142
210
A04AA02
ATC
granisetron; systemic, transdermal
+∞
58.8
55
*
WW500
NOMESCO Finland
Blood transfusion
30.2
57.2
77
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
14.9
55.2
96
82
L30.9
ICD-10 Finland
Dermatitis, unspecified
6.2
49.1
158
376
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
47.8
45
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
176.0
45.8
47
*
D07AB08
ATC
desonide; topical
7.5
44.0
114
198
JN4AD
NOMESCO Finland
Body CT examination
14.5
43.2
75
62
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
75.4
42.0
47
7
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
41.3
39
*
H02AB02
ATC
dexamethasone; systemic
33.5
40.7
53
18
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
22.3
39.6
58
30
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
39.2
37
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.8
38.9
108
204
A04AA01
ATC
ondansetron; systemic, rectal
23.3
38.2
55
27
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
38.1
36
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.6
36.6
65
56
E0000UV
ATC
NA
3.8
36.2
227
993
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
36.0
34
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.7
35.8
50
22
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
17.9
34.9
55
35
R50.9
ICD-10 Finland
Fever, unspecified
5.5
34.9
116
272
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
101.3
34.3
37
*
L26
ICD-10 Finland
Exfoliative dermatitis
+∞
32.7
31
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
32.7
31
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
32.7
31
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
78.4
32.4
36
5
H02AB06
ATC
prednisolone; systemic
3.5
32.4
269
1425
D70.82
ICD-10 Finland
Drug-induced neutropenia
76.0
31.4
35
5
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
30.6
29
*
D07AD01
ATC
clobetasol; topical
4.5
30.1
122
348
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
312.6
29.2
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.6
29.0
71
109
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
28.5
27
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
28.5
27
*
Z51.5
ICD-10 Finland
Palliative care
18.1
28.3
44
27
WF002
NOMESCO Finland
Radical radiotherapy
83.6
28.2
31
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
28.8
27.6
37
14
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
27.4
26
*
WW409
NOMESCO Finland
Other aferesis
+∞
26.3
25
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
276.8
26.0
26
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
276.8
26.0
26
*
D07AC01
ATC
betamethasone; topical
3.1
25.9
206
994
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.9
25.3
47
44
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
25.3
24
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
96.0
25.0
27
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
138.3
24.9
26
*
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
24.2
23
*
C84.1
ICD-10 Finland
Sézary disease
+∞
24.2
23
*
M04AA01
ATC
allopurinol; systemic
3.9
23.7
113
365
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
23.1
22
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
23.1
22
*
D05BB02
ATC
acitretin; oral
10.6
22.4
44
46
JN6AD
NOMESCO Finland
CT of torso and neck
55.2
22.3
26
5
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
66.3
22.1
25
*
D07AC13
ATC
mometasone; topical
3.0
22.0
167
757
ZX120
NOMESCO Finland
Intravenous
5.4
21.8
69
147
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
231.6
21.8
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
231.6
21.8
22
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
121.4
21.8
23
*
E000001
ATC
NA
3.3
21.5
128
490
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
21.0
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.0
20
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
115.8
20.8
22
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
115.8
20.8
22
*
N02AA05
ATC
oxycodone; systemic
4.2
20.4
85
241
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
19.9
19
*
L01AA02
ATC
chlorambucil; oral
+∞
19.9
19
*
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
209.5
19.7
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
19.5
222
1264
127
Kela drug reimbursment
Transplant complication
17.8
19.5
30
18
134
Kela drug reimbursment
General erythroderma
48.5
19.4
23
5
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
18.9
18
*
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.9
18
*
C10AB05
ATC
fenofibrate; oral
11.8
18.6
34
31
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
18.3
81
241
WZC30
NOMESCO Finland
Teaching
4.2
18.1
73
199
1XX25
NOMESCO Finland
NA
+∞
17.8
17
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
17.8
17
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
99.3
17.7
19
*
TQW80
NOMESCO Finland
Local dermatologic skincare
10.2
17.2
34
36
XX3DW
NOMESCO Finland
Time consuming IT work
6.4
17.2
46
79
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
16.8
16
*
J01MA12
ATC
levofloxacin; systemic
3.1
16.7
105
408
D02AE01
ATC
carbamide; topical
4.9
16.6
56
127
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
176.7
16.6
17
*
H02AB07
ATC
prednisone; oral
3.3
16.2
90
320
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.9
16.1
37
51
E000002
ATC
NA
3.8
16.0
72
216
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.1
16.0
30
29
J05AB11
ATC
valaciclovir; oral
3.4
15.8
83
283
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
14.9
131
621
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
14.7
14
*
H02AB09
ATC
hydrocortisone; systemic
9.7
14.4
29
32
J02AC01
ATC
fluconazole; systemic
2.4
14.2
150
781
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
13.9
95
384
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
13.7
144
748
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
13.6
13
*
ZX196
NOMESCO Finland
NA
+∞
13.6
13
*
HA1AA
NOMESCO Finland
X-ray mammography
8.3
13.3
29
37
D07AB02
ATC
hydrocortisone butyrate; topical
2.4
13.2
137
701
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
29.4
13.1
17
6
ZX112
NOMESCO Finland
Subcutaneous
19.8
13.0
19
10
XQ848
NOMESCO Finland
Dermatological photography
9.5
12.9
26
29
A07AA02
ATC
nystatin; oral
4.7
12.6
43
99
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
12.6
61
194
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
12.6
12
*
WW402
NOMESCO Finland
Leucoferesis
+∞
12.6
12
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.6
12
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
12.6
12
*
A02BC02
ATC
pantoprazole; systemic
2.2
12.4
281
2037
L04AD01
ATC
ciclosporin; systemic
10.1
12.4
24
25
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.3
12.4
38
78
E000006
ATC
NA
4.1
12.4
49
131
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.2
12.1
29
43
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
12.0
64
219
HAB40
NOMESCO Finland
Wedge excision of mammary gland
31.0
11.7
15
5
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
66.9
11.7
13
*
D07AA02
ATC
hydrocortisone; topical
2.9
11.5
74
287
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
11.5
11
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
11.5
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.5
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
11.5
11
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
5.4
11.5
34
67
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.7
11.5
24
29
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
11.4
31
55
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.9
11.1
36
79
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.1
11.0
24
31
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.4
10.9
28
46
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
18.4
10.8
16
9
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
28.9
10.8
14
5
JN4CD
NOMESCO Finland
Very extensive body CT
8.3
10.7
23
29
L20.0
ICD-10 Finland
Besnier prurigo
4.9
10.6
34
74
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
112.7
10.5
11
*
L41.8
ICD-10 Finland
Other parapsoriasis
112.7
10.5
11
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
10.5
10
*
B72
ICPC
Hodgkin Lymphoma
+∞
10.5
10
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
10.5
10
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
10.5
10
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
10.5
10
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
10.5
10
*
S18
ICPC
Laceration/cut
2.0
10.0
182
1168
E000003
ATC
NA
4.3
10.0
37
93
D02AX
ATC
Other emollients and protectives
5.9
10.0
27
48
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.6
9.9
17
14
JFB00
NOMESCO Finland
Partial resection of small intestine
12.6
9.9
17
14
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
13.8
9.7
16
12
L04AA06
ATC
mycophenolic acid; systemic
9.4
9.6
19
21
D69.5
ICD-10 Finland
Secondary thrombocytopenia
102.2
9.5
10
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
9.4
9
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
9.4
50
171
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.1
9.2
15
11
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.3
9.2
33
81
A05AA02
ATC
ursodeoxycholic acid; oral
10.4
9.1
17
17
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
37.5
9.1
11
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.7
9.0
20
27
D70.89
ICD-10 Finland
Neutropenic splenomegaly
19.1
9.0
13
7
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.9
8.9
15
12
TGC00
NOMESCO Finland
Bronchial lavation
5.6
8.9
25
47
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
8.8
31
75
L57.0
ICD-10 Finland
Actinic keratosis
3.2
8.8
46
156
J01DB01
ATC
cefalexin; oral
2.0
8.7
322
2622
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
51.1
8.7
10
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
51.1
8.7
10
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.5
8.7
18
22
L04AA01
ATC
[U] ciclosporin; systemic
11.9
8.6
15
13
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
8.6
25
49
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.8
8.6
54
207
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
8.5
99
523
E000007
ATC
NA
4.1
8.5
32
83
L41.4
ICD-10 Finland
Large plaque parapsoriasis
91.8
8.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
91.8
8.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
91.8
8.4
9
*
J02AC03
ATC
voriconazole; systemic
+∞
8.4
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
8.4
8
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
8.4
8
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
8.4
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
8.3
42
139
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
7.8
8.2
18
24
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
8.2
106
585
TK800
NOMESCO Finland
Hemodialysis
5.9
7.9
21
37
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.5
7.7
64
287
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
25.5
7.6
10
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.6
120
716
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
7.5
42
147
ZXC50
NOMESCO Finland
Cryotherapy
6.7
7.5
18
28
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.7
7.5
51
205
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
7.5
44
162
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.9
7.5
16
21
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
81.5
7.4
8
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
81.5
7.4
8
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
13.7
7.4
12
9
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
7.4
190
1332
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
9.6
7.3
14
15
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
7.3
7
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
7.3
7
*
C84
ICD-10 Finland
Mature T/NK-cell lymphomas
+∞
7.3
7
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
7.3
7
*
C84.2
ICD-10 Finland
T-zone lymphoma
+∞
7.3
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
7.3
7
*
C84.3
ICD-10 Finland
Lymphoepithelioid lymphoma
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
7.3
42
152
ZZR00
NOMESCO Finland
Flap of skin
30.6
7.2
9
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
7.1
105
605
ZX108
NOMESCO Finland
Inhalation
12.3
7.1
12
10
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
7.1
57
249
H03AA01
ATC
levothyroxine sodium; systemic
2.0
7.0
96
537
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
7.0
23
53
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
6.9
40
146
L03AB05
ATC
interferon alfa-2b; parenteral
40.7
6.8
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
40.7
6.8
8
*
RS340
NOMESCO Finland
NA
40.7
6.8
8
*
B01AB10
ATC
tinzaparin; parenteral
3.7
6.7
28
80
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
6.7
32
102
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
22.9
6.7
9
*
R06AE07
ATC
cetirizine; oral
1.8
6.7
158
1072
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.0
6.7
14
18
H26.3
ICD-10 Finland
Drug-induced cataract
12.5
6.6
11
9
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.3
6.6
12
12
D07XC01
ATC
betamethasone, combinations; topical
2.3
6.5
61
288
L30.3
ICD-10 Finland
Infective dermatitis
4.2
6.5
23
57
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
70.9
6.4
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
70.9
6.4
7
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
14.6
6.4
10
7
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.4
6.4
29
89
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.5
6.3
21
49
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
18.3
6.3
9
5
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
1AA09
NOMESCO Finland
NA
+∞
6.3
6
*
WF099
NOMESCO Finland
Other radiotherapy
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
6.3
6
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
6.3
6
*
J05AB01
ATC
aciclovir; systemic
2.0
6.3
85
472
N05CF01
ATC
zopiclone; oral
1.8
6.2
141
935
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
27.1
6.2
8
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
6.2
33
114
JAH00
NOMESCO Finland
Laparotomy
5.0
6.1
18
37
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.8
6.1
12
14
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.3
6.1
17
33
R4190
NOMESCO Finland
Nutritional therapy
6.2
6.0
15
25
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.4
6.0
20
47

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
182
104
28.38
237.13
2.2
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
102
46
28.24
143.29
5.4
2.8
u/ml
29322.1
467.1
—
28
8
(3011412) CD3 cells [#/volume] in Blood
80
18
53.64
137.75
3.4
1.6
e9/l
1.5
0.9
—
54
8
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
72
11
77.48
133.14
2.3
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
135
130
14.31
129.06
2.1
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
100
58
21.78
125.92
10.1
4.9
iu/ml
438.9
170.7
—
21
6
(3021879) Hepatitis B virus core Ab [Presence] in Serum
143
163
12.30
121.70
1.6
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
67
13
60.20
118.53
2.2
1.8
%
13.0
11.3
—
53
7
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
66
15
51.24
112.88
3.6
1.8
e6/l
393.5
1257.3
—
15
7
(3045142) Bone marrow Pathology biopsy report
72
27
31.45
107.19
1.6
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
75
50
17.74
87.32
2.3
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
155
287
7.65
86.55
2.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
160
313
7.32
84.60
2.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
177
389
6.79
83.16
2.0
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
76
8
113.61
71.40
1.7
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
283
1075
5.27
68.35
14.2
5.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
65
54
13.86
66.51
1.6
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
66
57
13.36
65.94
1.6
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
118
225
6.72
62.57
7.5
3.8
%
0.8
0.7
0.30
65
56
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
65
61
12.25
61.50
4.1
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
65
66
11.31
58.26
3.9
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
163
444
5.15
57.99
5.5
2.1
%
1.9
1.7
0.96
154
399
(3018010) Neutrophils/100 leukocytes in Blood
330
1548
5.05
57.54
14.3
5.2
%
56.5
57.8
1.07
325
1432
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
56
47
13.44
56.74
1.6
1.4
u/ml
179.6
117.8
—
10
8
(3000093) Morphology [Interpretation] in Blood Narrative
51
37
15.39
56.19
1.8
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
345
1703
5.16
55.48
14.5
5.3
e9/l
0.2
0.2
0.09
325
1493
(3019198) Lymphocytes [#/volume] in Blood
341
1670
5.08
55.37
14.0
5.1
e9/l
1.7
1.8
0.95
322
1458
(3001604) Monocytes [#/volume] in Blood
337
1640
4.99
55.06
13.9
5.0
e9/l
0.6
0.6
0.04
317
1408
(3006315) Basophils [#/volume] in Blood
338
1650
5.00
54.95
13.9
5.0
e9/l
0.0
0.0
1.53
317
1424
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
46
13.17
54.16
3.8
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
107
215
6.19
53.28
7.3
3.8
%
0.3
0.1
1.25
56
49
(3002179) Metamyelocytes/100 leukocytes in Blood
102
197
6.37
52.89
6.9
3.8
%
0.5
0.5
0.00
40
42
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
44
27
17.92
52.80
3.6
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
17
23.59
50.36
4.6
2.4
%
34.5
54.3
—
10
6
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
41
25
17.91
49.29
3.8
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
45
33
15.01
49.15
7.0
3.5
%
2.4
1.4
0.41
40
26
(3013650) Neutrophils [#/volume] in Blood by Automated count
347
1840
4.66
47.57
28.7
6.1
e9/l
3.8
4.4
4.67
326
1601
(3012095) Magnesium [Moles/volume] in Serum or Plasma
160
497
4.41
47.04
10.9
3.0
mmol/l
0.8
0.8
4.52
155
466
(3023520) Reticulocytes [#/volume] in Blood
127
330
4.94
46.90
5.1
2.2
e9/l
73.1
67.2
0.96
106
263
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
98
222
5.34
42.27
3.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
63
9.38
42.05
1.5
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
59
87
7.64
39.13
1.5
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
90
204
5.25
38.62
6.3
3.9
%
0.0
2.0
0.50
42
45
(40768804) Tissue Pathology biopsy report
225
996
3.47
37.80
3.1
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
36
29
13.39
37.07
1.5
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
36
29
13.39
37.07
3.0
2.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
83
184
5.29
36.44
1.7
1.2
g/l
1.0
1.1
0.33
78
169
(3023368) Bacteria identified in Blood by Culture
215
955
3.36
35.40
12.4
3.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
56
90
6.95
34.24
2.3
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
10
25.27
33.60
5.3
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
10
25.27
33.60
5.3
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
10
25.27
33.60
5.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
21
15.22
33.36
1.7
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
46
61
8.27
33.29
1.4
1.1
u/ml
351.8
262.0
0.66
30
32
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
37
37
10.79
33.13
2.1
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
32
26
13.16
32.71
4.6
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
32
26
13.16
32.71
4.6
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
32
26
13.16
32.71
4.6
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
275
1470
3.18
32.10
12.8
3.7
g/l
33.0
35.5
8.95
266
1350
(3008757) Leukocyte morphology finding [Identifier] in Blood
33
30
11.78
31.45
8.5
3.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
90
241
4.40
31.16
1.4
1.3
—
—
—
0
0
(44806118)
31
26
12.72
31.06
2.8
1.3
—
—
—
0
0
(44790049)
31
26
12.72
31.06
2.8
1.3
—
—
—
0
0
(44790048)
31
26
12.72
31.06
2.8
1.3
—
—
—
0
0
(44790047)
31
26
12.72
31.06
2.8
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
209
972
3.12
30.89
7.2
2.5
umol/l
1709.7
8907.1
2.57
200
837
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
54
8.24
29.78
2.4
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
88
241
4.28
29.50
1.4
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
292
1681
3.03
28.68
20.0
4.1
umol/l
11.3
12.4
0.66
286
1564
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
67
154
4.92
27.93
1.8
1.6
g/l
1.7
1.5
0.63
59
133
(40758558) Short blood count panel - Blood
169
749
2.99
26.45
22.7
4.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
45
8.34
25.87
1.9
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
30
7
45.65
24.88
1.2
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
26
10.97
24.67
8.0
2.7
%
58.4
51.5
0.48
21
20
(3024471) HLA-A [Type]
19
10
19.78
24.05
1.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
139
588
2.96
23.25
4.1
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
11
17.98
23.02
8.0
2.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
207
1084
2.66
22.84
8.3
2.0
mmol/l
2.3
2.3
0.52
199
880
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
87
5.63
22.69
2.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
32
9.25
22.64
2.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
70
6.17
22.35
3.1
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
21
0
+∞
22.05
1.3
0.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
149
671
2.81
22.03
10.6
3.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
28
9.78
21.95
1.8
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
359
3.24
21.49
9.6
2.5
umol/l
6.2
7.7
0.68
92
312
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
46
7.40
21.47
2.7
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
28
35
8.46
21.11
4.1
2.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
41
7.76
21.02
2.7
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
57
147
4.29
20.41
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
36
62
6.22
20.41
1.4
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
17
10
17.62
20.38
1.5
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
121
506
2.89
20.38
2.4
2.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
41
81
5.46
20.16
1.3
2.0
mg/l
12.9
12.9
0.01
34
75
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
95
351
3.15
19.89
5.0
3.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
101
392
3.02
19.38
2.2
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
55
6.39
19.31
1.2
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
31
8.47
18.93
4.0
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
243
1464
2.41
18.81
19.9
8.2
e9/l
0.0
0.0
0.38
210
1197
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
138
4.21
18.71
1.3
2.2
u/l
43.3
38.5
0.66
46
120
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
32
8.21
18.45
4.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
32
8.21
18.45
4.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
32
8.21
18.45
4.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
32
8.21
18.45
4.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
32
8.21
18.45
4.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
184
987
2.44
18.41
7.4
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
267
1689
2.39
18.32
17.1
5.7
mmol/l
1.2
1.2
0.45
228
1443
(21494434) Karyotype in Bone marrow
26
36
7.60
17.98
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
102
414
2.88
17.96
2.5
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
53
6.20
17.67
5.3
3.0
%
53.7
58.5
1.04
31
53
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
9
26.80
17.07
2.4
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
9
26.80
17.07
2.3
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
240
1483
2.30
16.95
10.4
3.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
27
43
6.61
16.46
2.7
1.7
pg
34.6
33.7
0.59
27
43
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
99
413
2.78
16.45
3.1
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
114
4.27
16.43
2.7
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
98
411
2.76
16.09
3.3
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
128
613
2.51
16.06
1.6
1.2
g/l
2.6
2.8
0.32
98
350
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
20
6
34.75
15.86
2.6
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
20
6
34.75
15.86
2.5
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
61
5.38
15.27
1.5
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
240
1542
2.17
14.71
14.6
5.5
mmol/l
1.2
1.2
0.39
232
1372
(3008536) Aspergillus sp Ab [Presence] in Serum
18
5
37.37
14.54
3.8
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
59
197
3.29
14.42
1.7
1.2
u/ml
2467.8
249.2
0.67
52
178
(40760888) Immunoglobulin light chains.free panel - Serum
33
73
4.79
14.23
1.5
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
231
1477
2.14
14.17
11.7
10.6
inr
1.2
1.4
1.25
57
413
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
58
5.27
14.02
1.2
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
43
119
3.88
13.92
1.6
1.2
g/l
0.5
0.4
0.09
38
106
(3018418) pH of Serum or Plasma
171
985
2.17
13.61
10.6
3.1
ph
7.4
7.4
0.40
37
166
(3035933) Granulocytes/100 leukocytes in Blood
13
10
13.35
13.42
2.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
53
173
3.33
13.41
1.9
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
142
764
2.24
13.35
6.7
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
13
11.08
12.91
1.4
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
13
11.08
12.91
1.3
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
22
37
6.20
12.71
2.0
3.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
11
12.13
12.68
1.2
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
103
3.93
12.65
1.5
1.3
mg/l
73.4
44.4
0.90
29
87
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
103
3.93
12.65
1.5
1.3
mg/l
55.8
32.2
1.17
28
88
(3013707) Erythrocyte sedimentation rate by Westergren method
344
2626
2.25
12.61
7.3
4.0
mm/h
16.2
12.2
3.97
335
2388
(3036481) Cortisol [Moles/volume] in Serum or Plasma
73
298
2.72
12.46
3.2
1.6
nmol/l
372.9
368.5
0.06
68
270
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
66
258
2.82
12.22
3.0
2.0
g/l
0.2
0.2
0.11
61
229
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
183
3.14
12.22
2.1
1.3
ug/l
3.7
4.4
0.14
42
143
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
123
652
2.21
11.81
9.0
2.1
mmol/l
2.5
2.4
2.84
115
544
(3037522) Nuclear Ab [Titer] in Serum
92
439
2.37
11.28
1.5
1.3
titre
380.0
475.7
0.44
20
111
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
144
3.27
11.07
1.5
1.3
g/l
4.3
4.0
0.42
33
104
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
144
3.27
11.07
1.5
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
144
3.27
11.07
1.5
1.3
g/l
7.2
7.6
0.64
33
108
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
14
5
28.80
10.78
1.8
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
136
3.30
10.74
1.5
1.3
g/l
3.3
3.2
0.28
33
106
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
7
22.09
10.74
7.8
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
14
17
8.46
10.66
1.6
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
194
1264
1.93
10.35
4.3
2.9
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
17
28
6.27
9.99
1.2
1.6
—
314.0
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
148
3.10
9.95
5.3
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
127
725
2.04
9.84
2.6
1.7
mg/l
1.9
1.2
2.20
112
565
(3013826) Glucose [Moles/volume] in Serum or Plasma
285
2126
1.90
9.83
9.3
4.4
mmol/l
6.6
6.8
1.01
273
1999
(3002582) Erythrocytes [#/volume] in Urine
167
1051
1.93
9.76
4.3
2.9
e6/l
15.2
124.9
1.09
132
807
(3002032) Base excess in Venous blood by calculation
78
368
2.35
9.74
6.1
3.2
mmol/l
1.2
2.1
0.95
66
300
(3014576) Chloride [Moles/volume] in Serum or Plasma
89
448
2.22
9.53
16.7
5.3
mmol/l
104.4
104.2
0.15
89
436
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
26
6.34
9.52
1.3
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
67
299
2.45
9.45
11.8
7.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
137
815
1.97
9.40
1.6
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
47
178
2.83
9.19
6.3
3.4
mmol/l
24.0
24.3
0.16
47
159
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
31
5.66
9.04
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
18
7.40
8.89
1.3
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
40
4.91
8.66
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
6
20.48
8.51
1.3
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
30
5.49
8.26
1.4
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
27
5.71
8.07
1.5
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
5
22.48
8.05
2.6
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
14
8.03
8.02
2.4
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
14
8.03
8.02
2.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
218
2.51
7.86
2.4
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
115
682
1.92
7.79
3.5
2.4
mosm/kgh2o
561.7
563.5
0.03
100
563
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
13
21
6.34
7.75
1.2
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24
67
3.72
7.68
2.5
1.6
u/ml
35.3
195.8
0.65
18
50
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
18
6.82
7.64
2.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
25
5.75
7.58
2.6
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
149
966
1.80
7.58
4.1
2.8
e6/l
0.2
0.5
5.22
119
720
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
20
50
4.14
7.42
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
22
6.05
7.42
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
89
3.29
7.39
1.4
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
158
1050
1.77
7.35
7.6
2.7
u/l
35.8
38.2
0.30
151
994
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
463
2.03
7.32
2.8
2.4
%
23.5
23.4
0.01
73
396
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
47
4.17
7.15
1.3
1.7
g/l
0.8
1.0
0.20
11
39
(36304419) Bacteria [Presence] in Urine
141
913
1.79
7.14
4.1
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
36
136
2.79
7.08
2.5
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
55
257
2.30
6.97
7.3
3.5
ph
7.4
7.4
—
6
28
(40768806) Pleura Pathology biopsy report
12
20
6.13
6.94
1.5
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
35
132
2.79
6.91
1.5
1.5
—
193.3
—
0
9
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
245
2.32
6.89
7.4
3.5
mmol/l
2.3
2.0
0.22
45
182
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
28
5.13
6.74
1.3
1.2
g/l
0.3
0.3
—
9
22
(4062490)
14
28
5.13
6.74
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
28
5.13
6.74
1.3
1.2
g/l
6.6
6.6
—
9
22
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
28
5.13
6.74
1.3
1.2
g/l
3.0
2.4
—
9
21
(3000850) Epithelial cells [#/volume] in Urine
115
714
1.82
6.64
3.5
2.2
e6/l
4.3
4.8
0.31
102
621
(3004789) Transferrin [Mass/volume] in Serum or Plasma
87
494
1.94
6.63
2.7
2.3
g/l
2.2
2.3
0.48
81
451
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
21
5.84
6.62
1.3
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
101
3.00
6.60
2.7
3.1
u/ml
0.3
0.4
0.11
17
60
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
102
2.97
6.49
1.8
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
103
2.94
6.38
1.8
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
40
169
2.50
6.33
8.4
3.9
mmol/l
25.3
24.9
0.29
40
158
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
173
1223
1.67
6.22
4.9
3.4
e6/l
125.3
120.7
0.02
136
868
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
94
559
1.86
6.20
3.6
2.8
e6/l
4.7
2.0
0.44
60
299
(42529406) Shigella sp [Presence] in Stool by Culture
29
105
2.88
6.17
1.8
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
160
1111
1.68
6.15
3.6
2.2
u/l
71.3
56.8
0.31
150
1018
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
54
266
2.17
6.03
3.4
3.9
ng/l
100.5
89.4
0.25
49
235
(3022948) Iron [Moles/volume] in Serum or Plasma
92
552
1.83
5.88
2.8
2.3
umol/l
12.3
12.9
0.26
85
505
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
135
906
1.69
5.85
2.6
2.2
mg/l
3.4
3.0
0.77
125
763
(21494890) Protein electrophoresis panel - 24 hour Urine
13
28
4.75
5.77
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
17
5.99
5.65
2.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
29
4.58
5.54
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
185
1367
1.59
5.39
2.4
2.2
nmol/l
75.1
77.0
0.41
169
1181
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
8
11.44
5.31
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
8
11.44
5.31
3.0
6.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
0
+∞
5.22
2.6
0.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
186
1385
1.58
5.20
3.8
2.7
ug/l
657.6
143.4
3.44
172
1261
(3052851) Hemolysis interference index of Serum or Plasma
25
92
2.82
5.19
3.2
3.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
199
2.22
5.17
8.3
3.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
6
13.54
5.09
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
113
748
1.68
5.08
4.5
4.1
ng/l
165.4
354.9
0.87
95
615
(3003740) Influenza virus B Ag [Presence] in Specimen
14
36
3.98
5.02
1.6
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
144
1017
1.61
5.00
3.5
3.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
37
3.87
4.85
1.6
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
7
11.60
4.80
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
20
5.09
4.80
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
17
52
3.36
4.79
2.1
1.2
iu/l
25.1
26.8
0.07
17
45
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
172
2.25
4.77
11.3
12.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
38
3.77
4.68
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
61
345
1.89
4.66
13.3
3.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
148
2.33
4.62
1.8
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
115
783
1.63
4.59
1.8
1.7
nmol/l
967.5
1184.8
1.79
94
596
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
5
14.18
4.59
1.4
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
69
409
1.81
4.55
9.8
7.8
kpa
11.1
11.4
0.21
63
397
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
69
409
1.81
4.55
9.8
7.8
kpa
4.7
5.1
3.17
63
395
(3048879) Bone marrow aspiration report
8
8
10.15
4.53
3.7
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
8
10.15
4.53
2.5
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
286
2388
1.53
4.51
5.8
4.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
6
11.82
4.29
1.3
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
68
410
1.77
4.24
9.8
7.8
mmol/l
-0.3
1.4
1.76
51
321
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
79
2.74
4.21
1.2
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
63
2.93
4.11
1.7
1.3
miu/ml
72.2
273.7
—
5
25
(40768800) Prostate Pathology biopsy report
10
23
4.42
4.11
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
10
24
4.24
3.90
1.1
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
11
7.38
3.87
2.3
1.3
umol/l
27.6
27.8
—
8
11
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
15
6.10
3.83
1.3
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
20
78
2.64
3.77
1.5
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
89
600
1.60
3.65
3.5
2.6
e6/l
1.1
1.1
0.05
56
337
(3003327) Ova and parasites identified in Stool by Light microscopy
22
92
2.46
3.62
1.6
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
162
1247
1.46
3.58
3.2
3.1
ng/l
2686.9
1606.3
0.57
146
1071
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
31
152
2.11
3.55
3.0
3.1
pmol/l
4.1
4.4
1.19
26
132
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
27
3.76
3.37
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
14
5.79
3.35
1.3
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
14
5.79
3.35
1.3
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
116
2.22
3.29
3.4
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
66
2.64
3.25
1.7
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
24
110
2.25
3.25
5.5
10.7
mmol/l
1.4
1.3
0.27
19
103
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
33
3.39
3.21
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
15
5.41
3.20
1.3
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
79
2.47
3.18
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
79
2.47
3.18
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
264
1.78
3.09
4.8
3.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
29
3.50
3.06
1.4
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
16
5.07
3.06
1.3
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
41
235
1.82
3.04
2.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
17
69
2.52
2.99
7.2
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
23
108
2.19
2.96
1.9
1.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
13
5.45
2.88
1.9
1.3
u/l
213.0
201.4
—
7
13
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
9
6.74
2.87
7.0
3.3
%
136.3
76.8
—
6
9
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
36
3.11
2.82
1.2
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
18
4.50
2.80
1.8
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
6
8.41
2.75
2.0
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
54
345
1.64
2.75
2.3
2.2
ug/g
177.6
122.7
0.64
45
270
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
14
5.06
2.73
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
60
2.55
2.73
1.3
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
10
6.06
2.70
1.8
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
19
4.27
2.69
1.5
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
32
3.17
2.66
1.2
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
74
2.35
2.61
1.8
1.2
ug/g
269.8
302.5
0.32
12
38
(3026389) Candida sp identified in Specimen by Organism specific culture
12
44
2.77
2.56
1.3
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
7
7.21
2.55
1.8
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.21
2.55
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
21
3.86
2.47
1.6
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
57
2.50
2.47
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
12
5.05
2.41
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
12
5.05
2.41
1.0
1.2
ug/l
10.1
8.8
—
6
12
(3051611) Lipemic interference index of Serum or Plasma
9
27
3.38
2.40
3.1
2.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
71
2.30
2.37
2.3
1.9
%
16.1
16.4
—
7
33
(3051651) Icteric interference index of Serum or Plasma
7
17
4.16
2.37
3.4
2.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
29
3.14
2.23
1.8
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
9
5.60
2.22
1.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
9
5.60
2.22
1.2
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
19
3.72
2.16
1.3
1.2
mmol/l
3.0
2.1
—
7
19
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
189
1595
1.31
2.16
2.2
2.0
pmol/l
88.5
93.9
0.70
122
815
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
14
4.33
2.15
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
222
1.67
2.13
2.1
2.7
e9/l
3.4
4.0
0.78
28
155
(40761535) Cells panel - Urine sediment
49
327
1.56
2.12
3.8
2.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
89
2.06
2.08
1.3
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
311
3377
0.75
2.07
6.6
6.5
mmol/mol
40.3
40.7
0.31
288
3121
(3021960) Folate [Moles/volume] in Serum or Plasma
118
937
1.35
2.03
1.8
1.5
nmol/l
17.7
20.4
1.30
101
791
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
42
274
1.59
2.01
3.2
2.0
ml/min/173m2
67.6
61.2
0.38
17
109
(3032773) Endomysium IgG Ab [Titer] in Serum
7
21
3.37
1.97
1.1
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
51
2.39
1.96
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
329
1.51
1.86
1.4
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
66
2.16
1.83
1.6
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
23
3.07
1.80
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
29
2.79
1.80
1.3
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
24
2.95
1.73
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
110
885
1.32
1.72
3.9
3.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
88
685
1.35
1.72
1.3
1.3
u/ml
1.9
1.5
0.24
21
193
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
13
3.88
1.72
1.0
2.1
nmol/l
3.9
4.1
—
5
13
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
31
2.61
1.66
1.3
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
128
1.76
1.63
1.9
2.3
g/l
0.4
0.2
0.42
13
41
(3027315) Oxygen [Partial pressure] in Blood
15
77
1.98
1.61
8.7
3.2
kpa
8.2
8.2
0.05
15
77
(3013290) Carbon dioxide [Partial pressure] in Blood
15
77
1.98
1.61
8.7
3.2
kpa
5.3
5.0
0.95
15
77
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
370
3481
1.33
1.60
43.5
13.1
mg/l
26.2
24.7
0.36
342
2697
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
339
3602
0.77
1.59
6.0
5.4
mmol/l
2.7
2.6
1.00
316
3290
(3023419) Bacteria identified in Sputum by Culture
12
57
2.14
1.56
7.8
2.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
44
2.30
1.54
1.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
37
2.46
1.48
1.8
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
38
2.40
1.46
1.2
1.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
28
2.52
1.45
1.4
1.2
—
85.4
—
0
5
(3019060) Gas panel - Arterial blood
37
255
1.49
1.43
5.2
6.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
46
2.20
1.41
1.1
1.0
g/l
1.7
1.5
—
10
39
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
40
2.27
1.41
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
329
3492
0.79
1.39
5.6
4.8
mmol/l
1.3
1.4
4.96
311
3185
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
17
2.96
1.36
2.4
2.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
281
2586
1.22
1.31
6.2
3.6
pmol/l
14.6
15.0
2.31
264
2328
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
43
2.11
1.31
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
43
2.11
1.31
2.2
3.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
34
2.38
1.29
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
214
0.55
1.25
3.0
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
70
554
1.31
1.24
25.1
28.2
inr
1.4
1.3
0.13
16
75
(3009261) Glucose [Presence] in Urine by Test strip
192
1708
1.21
1.24
3.9
3.6
estimate
0.0
0.0
0.00
46
264
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
173
1525
1.22
1.22
4.6
3.9
ng/l
35.5
47.9
1.09
134
1122
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
187
0.52
1.21
1.8
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
189
1682
1.21
1.21
5.3
4.9
estimate
0.0
0.0
0.00
49
268
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
56
431
1.34
1.20
1.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
26
2.32
1.19
1.5
1.0
—
—
—
0
0
(3013512) EKG study
131
1126
1.23
1.18
5.1
4.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
35
251
1.43
1.14
7.3
8.6
mmol/l
24.3
24.5
0.10
30
238
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
192
1.49
1.14
1.2
1.2
iu/ml
72.4
93.4
—
5
73
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
363
0.67
1.14
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
61
481
1.31
1.12
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
96
1.69
1.11
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
335
3522
0.82
1.10
6.6
4.8
mmol/l
4.5
4.5
0.38
320
3236
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
166
0.53
1.10
1.7
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
41
1.97
1.09
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
237
0.62
1.02
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
65
526
1.27
1.00
1.3
1.3
u/ml
1.0
12.2
3.50
29
191
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
23
2.19
0.98
1.2
1.7
nmol/l
0.6
1.1
—
5
15
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
23
2.19
0.98
1.6
1.5
g/l
0.8
1.0
—
5
23
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
99
844
1.22
0.96
1.8
1.8
pmol/l
620.8
5789140.5
0.50
84
691
(4034850)
8
146
0.54
0.94
27.0
10.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
186
1687
1.17
0.91
4.0
3.5
estimate
0.0
0.0
0.00
48
271
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
203
1857
1.17
0.89
3.0
2.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
46
1.75
0.83
1.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
66
1.68
0.79
3.6
2.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
146
1317
1.16
0.75
4.3
3.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
103
905
1.18
0.74
4.5
3.7
estimate
0.0
0.0
0.50
46
263
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
237
2216
1.14
0.73
5.9
3.0
u/l
76.7
49.1
2.36
222
2043
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
122
1359
0.86
0.72
3.9
3.8
%
20.7
24.0
1.43
54
642
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
40
1.76
0.71
1.1
1.3
pmol/l
89.7
57.0
—
7
40
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
484
0.79
0.71
20.0
6.9
—
—
—
0
0
(3000492) Spirometry study
41
330
1.27
0.69
1.7
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
379
3893
0.85
0.65
58.8
19.2
e9/l
218.7
239.9
6.14
372
3774
(3045414) Leukocytes [Presence] in Urine
17
122
1.41
0.61
1.8
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
64
1.58
0.59
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
380
3896
0.86
0.58
58.6
19.2
e9/l
6.8
6.8
0.04
373
3761
(3050129) First trimester maternal screen panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
342
3531
0.88
0.58
6.2
4.9
mmol/l
6.0
6.1
0.96
316
3192
(3026361) Erythrocytes [#/volume] in Blood
380
3895
0.86
0.58
58.6
19.2
e12/l
4.2
4.5
21.16
373
3757
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
239
0.74
0.55
1.6
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
269
2565
1.12
0.55
5.1
4.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
46
1.53
0.48
4.9
2.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
111
1.36
0.47
1.5
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
105
1145
0.89
0.45
3.1
3.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
194
1.25
0.43
2.4
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
57
1.41
0.42
1.5
1.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
15
0.00
0.41
0.0
1.1
—
285.0
—
0
6
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
34
1.48
0.40
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
103
0.67
0.40
1.1
1.6
—
—
—
0
0
(4010399)
22
268
0.81
0.38
1.3
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
330
3382
0.91
0.36
6.7
4.3
mmol/l
1.5
1.3
3.84
314
3060
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
122
0.73
0.35
1.2
1.8
nmol/l
40.4
42.1
—
9
117
(3022621) pH of Urine by Test strip
27
227
1.20
0.35
2.6
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
119
1.27
0.32
1.7
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
338
3310
1.08
0.28
34.7
11.9
ml/min/173m2
76.6
76.6
0.01
309
2657
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
140
0.78
0.28
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
162
1694
0.93
0.28
4.2
3.9
ug/l
2.4
2.0
0.35
147
1511
(3009508) Creatinine [Moles/volume] in Urine
122
1285
0.93
0.26
3.0
3.1
mmol/l
7.5
7.8
0.44
97
1050
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
73
1.24
0.25
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
316
3096
1.07
0.24
37.1
14.5
%
37.3
39.9
4.30
215
2072
(4268621)
5
39
1.29
0.23
1.6
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
10
79
1.27
0.22
1.3
1.4
nmol/l
1.2
0.8
—
10
64
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
18.9
—
0
10
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(1002224) Polysomnography panel
11
134
0.82
0.21
1.1
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
8.6
—
0.7
—
0
13
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
89
939
0.94
0.20
2.8
2.7
ug/l
0.6
0.7
0.79
61
632
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.7
—
0
5
(37021550) Renin [Units/volume] in Plasma --upright
0
14
0.00
0.20
0.0
1.2
—
119.2
—
0
9
(36660697) Celiac disease serology panel - Serum
28
251
1.12
0.19
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
77
812
0.94
0.17
4.3
3.9
kg/l
1.0
1.0
0.33
11
118
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
62
1.13
0.17
3.0
2.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
63
1.11
0.17
3.0
2.4
mmol/l
4.0
4.1
—
7
63
(3035285) Chloride [Moles/volume] in Venous blood
7
63
1.11
0.17
3.0
2.4
mmol/l
105.0
105.0
—
7
63
(3024928) Oxygen saturation in Venous blood
11
92
1.20
0.16
2.5
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
78
0.77
0.15
1.2
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
86
0.81
0.14
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
89
0.78
0.14
1.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
99
0.80
0.13
2.5
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
229
1.10
0.12
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
39
366
1.07
0.12
1.7
1.8
%
1.4
1.6
1.78
33
311
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
563
1.06
0.11
1.3
1.3
iu/ml
9.9
36.3
5.85
17
173
(3020682) Albumin/Creatinine [Ratio] in Urine
128
1312
0.97
0.10
3.8
3.9
mg/mmol
9.8
7.6
0.25
81
827
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
493
0.95
0.10
5.0
4.9
%
27.5
32.3
3.24
42
326
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.3
nmol/l
0.7
0.6
—
5
42
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.8
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
122
1246
0.97
0.08
3.0
3.2
mg/l
454.9
205.5
0.30
73
795
(3023103) Potassium [Moles/volume] in Serum or Plasma
370
3723
0.97
0.07
43.9
16.2
mmol/l
4.0
4.0
1.70
364
3615
(40761511) CBC panel - Blood by Automated count
364
3658
0.98
0.05
33.1
12.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
200
1.05
0.04
3.6
3.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
322
3205
1.02
0.03
6.1
4.4
mu/l
1.9
2.0
0.89
304
2886
(3019550) Sodium [Moles/volume] in Serum or Plasma
370
3713
0.98
0.03
43.1
16.1
mmol/l
139.1
139.8
5.57
364
3606
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
300
0.96
0.03
1.9
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
11
102
1.08
0.03
1.8
1.7
e6/l
7377.8
14326.2
0.67
11
75
(3011397) Hemoglobin [Presence] in Urine by Test strip
82
829
0.99
0.01
3.4
3.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
97
979
0.99
0.01
2.1
1.6
mmol/l
1.7
1.3
2.36
88
800
(3020891) Body temperature
15
157
0.95
0.01
8.8
4.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
187
0.96
0.01
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
108
1.02
0.00
3.6
4.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
36.5
—
0
8
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
1.8
4.1
umol/l
324.6
349.0
—
5
42
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
75
0.93
0.00
2.6
1.9
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
-0.00
0.0
1.0
—
108.2
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
-0.00
0.0
1.0
—
23.6
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
-0.00
0.0
1.2
—
1.9
—
0
6
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
-0.00
0.0
1.0
—
7.6
—
0
6
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
6
0.00
-0.00
0.0
1.2
—
0.7
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_TNK_LYMPHOMA_EXALLC – Mature T/NK-cell lymphomas, hilmo, excluding all cancers

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).